Form D · Biotechnology
Ascyrus Medical, LLC
Boca Raton, FL · CIK 0001800825
Offering snapshot reported Jan 31, 2020 · SEC filing
- Reported sold
- $5.18M Offering amount: $5.18M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $40K Reported outside-investor minimum
- First sale
- Jan 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 31, 2020 | Initial | $5,180,014 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-359427
Source: Form D, filed Jan 31, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ali Shahriari | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2385 Nw Executive Center Drive Suite 100
Boca Raton, FL, 33431
Boca Raton, FL, 33431